288 related articles for article (PubMed ID: 28103579)
21. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram.
Sun Y; Zhang Y; Huang Z; Chi P
J Gastrointest Surg; 2019 May; 23(5):1006-1014. PubMed ID: 30187336
[TBL] [Abstract][Full Text] [Related]
23. [Postoperative pathological staging correlates the prognosis of rectal cancer after neoadjuvant chemoradiotherapy].
Xiao Y; Lu J; Xiong G; Wu B; Lin G; Zhao L; Liang Z; Zhong G; Hu K; Pan W; Qiu H
Zhonghua Wai Ke Za Zhi; 2014 Feb; 52(2):99-104. PubMed ID: 24809516
[TBL] [Abstract][Full Text] [Related]
24. Worse prognosis in young patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A comparative study.
Zhang Y; Wang Y; Liu X; Chen B; Zhuang J; Li S; Yang Y; Su Y; Guan G
Medicine (Baltimore); 2020 Aug; 99(35):e21304. PubMed ID: 32871861
[TBL] [Abstract][Full Text] [Related]
25. Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
Choi JP; Kim SJ; Park IJ; Hong SM; Lee JL; Yoon YS; Kim CW; Lim SB; Lee JB; Yu CS; Kim JC
Oncotarget; 2017 Feb; 8(6):10375-10384. PubMed ID: 28060748
[TBL] [Abstract][Full Text] [Related]
26. What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
Kim SH; Chang HJ; Kim DY; Park JW; Baek JY; Kim SY; Park SC; Oh JH; Yu A; Nam BH
Cancer Res Treat; 2016 Jul; 48(3):998-1009. PubMed ID: 26511803
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer.
Zhang H; Sun G; Zheng K; Lou Z; Gao XH; Meng RG; Furnée EJB; Zhang W
ANZ J Surg; 2021 Apr; 91(4):E190-E195. PubMed ID: 33559307
[TBL] [Abstract][Full Text] [Related]
28. A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Saito G; Miyakita H; Akiba T; Yamamuro H
Oncology; 2017; 93(5):287-294. PubMed ID: 28728151
[TBL] [Abstract][Full Text] [Related]
29. [Expression of CD133 in rectal cancer tissues and its relationship with neoadjuvant chemoradiotherapy].
Li D; Wu H; Feng R; Zhong D; Luo Y; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):690-4. PubMed ID: 27353106
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of risk factors of distant metastasis in rectal cancer patients who received total mesorectal excision following neoadjuvant chemoradiotherapy].
Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Ye D; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):436-41. PubMed ID: 27112480
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
[TBL] [Abstract][Full Text] [Related]
32. Impact of neoadjuvant therapy on nodal harvest in clinical stage III rectal cancer: Establishing optimum cut-offs by disease response.
Wehrle CJ; Woo K; Chang J; Gamaleldin M; DeHaan R; Dahdaleh F; Felder S; Rosen DR; Champagne B; Steele SR; Naffouje SA
J Surg Oncol; 2024 Apr; 129(5):945-952. PubMed ID: 38221655
[TBL] [Abstract][Full Text] [Related]
33. Correlative Significance of Tumor Regression Grade and ypT Category in Patients Undergoing Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer.
Ryu HS; Lee JL; Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JH; Kim JC
Clin Colorectal Cancer; 2022 Sep; 21(3):212-219. PubMed ID: 35300935
[TBL] [Abstract][Full Text] [Related]
34. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
[TBL] [Abstract][Full Text] [Related]
36. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
[TBL] [Abstract][Full Text] [Related]
37. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Significance of Clinicopathological and Molecular Features After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.
Cho HJ; Baek JH; Baek DW; Kang BW; Lee SJ; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
In Vivo; 2019; 33(6):1959-1965. PubMed ID: 31662525
[TBL] [Abstract][Full Text] [Related]
39. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
[TBL] [Abstract][Full Text] [Related]
40. Effect of Responsiveness of Lymph Nodes to Preoperative Chemoradiotherapy in Patients With Rectal Cancer on Prognosis After Radical Resection.
Lee HG; Kim SJ; Park IJ; Hong SM; Lim SB; Lee JB; Yu CS; Kim JC
Clin Colorectal Cancer; 2019 Jun; 18(2):e191-e199. PubMed ID: 31014994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]